Joldon Phone Number: 800.661.4556
Joldon Fax Number: 800.661.4557
Request a Quote
Joldon Email Address:


A market survey of 317 hospitals, conducted by the Enterprise Analysis Corporation in 2007 and updated in 2008, reveals substantial growth in the number of hospitals performing point-of-care testing (POCT).

Abstract: Quantitative Point-of-Care Troponin I in Emergency Department in Comparison With Troponin I in Central Laboratory
  • Point of Care: The Journal of Near-Patient Testing & Technology:
  • March 2010 - Volume 9 - Issue 1 - pp 12-20
  • doi: 10.1097/POC.0b013e3181d07e22
  • Original Articles
  • Many patients may present simultaneously in emergency departments. We must ensure that patients are treated in the order of their clinical urgency and that the treatment is appropriate and timely. Rapid cardiac marker testing may aid in early detection of acute coronary syndromes. It is almost impossible for laboratories to deliver cardiac biomarker results in less than 30 minutes, using serum- or plasma-based assays. Use of plasma for measurement of cardiac biomarkers eliminates the clotting process involved in producing serum and therefore reduces the overall turnaround time for biomarker testing.

    Point-of-care devices allow cardiac troponin I testing using anticoagulated whole blood specimens at the site of patient care delivery. Elimination of transport and centrifugation can reduce the overall turnaround time to less than 30 minutes.

    View our Test Catalogue